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inetics of Chikungunya infection during an outbreak in south-
rn Thailand, 2009
. Chusri1,∗, P. Siripaitoon1, K. Silpapojakul1, T. Hortiwakul1, A.
isalak2, B. Thaisomboonsuk2, C. Klungthong2, R.V. Gibbons2, R.
arman2
Prince of Songkla University, Songkhla, Thailand
Armed Forces Research Institute of Medical Sciences, Bangkok,
hailand
Background: Background. The Indian ocean Chikungunya epi-
emic, reemerged in Southern Thailand in September of 2009.
Methods:Methods. Forty-ﬁve adultswith laboratory conﬁrmed
hikungunya were enrolled. Serial blood collections and clinical
ssessments were performed every two-three days through the
cute and convalescent phase of the disease. Patient symptoms,
ntibody responses, and viral kinetics were evaluated using PCR
nd serological assays.
Results: Results. The patients mean age was 49 years with a
ale to female ratio of 1:1.4. Thirty-ﬁve patients (77.8%) patients
ere gardeners. All patients experienced joint pain and 42 (93%)
nvolving more than one joint. Interphalageal joints were the most
ommon affected in 41 (91%) patients. Themean duration of severe
oint pain was 5.8 days with 11 (25%) experiencing discomfort
hrough the duration of the study. Rash was observed in 37 (82%)
atients, amean3.5 days after the onset of symptoms. Patentswere
ositive by PCR for amean of 5.9 dayswith a peak viral load at day 5
ith 6.24 log PFU/ml. IgMantibodies appeared onday 4 andpeaked
t day 7 and IgG antibodies ﬁrst appeared at day 5 and rose steadily
hrough day 24. The plaque reduction neutralizing test (PRNT) of
erially acute and convalescent phase are performed to quantify
he levels of anti-chikungunya neutralizing antibodies. The PRNT
esult is in progress.
Conclusion: Conclusions. Understanding chikungunya disease
ymptoms, antibody responses and viral kinetics are important in
iagnosis and treating the disease.
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Simple clinical and laboratory predictors of chikungunya versus
dengue infections in adults
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Background: Dengue and chikungunya are co-circulating
vector-borne diseases with substantial overlap in clinical presen-
tations. Because they require different clinical management, it is
important to be able to differentiate between them during ﬁrst
presentation, especially for dengue haemorrhagic fever (DHF). This
study compares their clinical presentation in Singapore adults to
derive predictors to assist doctors in diagnostic decision-making.
Methods: We compared 117 adult patients with chikungunya
infection on reverse transcription-polymerase chain reaction (PCR)
with 917 dengue PCR-positive adult patients (including 55 with
DHF) hospitalized at Tan Tock Seng Hospital, Singapore, the
national outbreak response centre. We compared dengue fever
(DF), DHF, and chikungunya infections by comparing clinical char-
acteristics of dengue and chikungunya; developing classiﬁcation
tools via multivariate logistic regression models and classiﬁcation
trees of disease etiology using clinical and laboratory factors; and
assessing the time course of several clinical variables using hierar-
chical Bayesian methods. Tools that only used predictors available
in lower-resourced settings were also developed.
Results: At ﬁrst presentation to hospital, signiﬁcantly more
chikungunya patients had myalgia or arthralgia, and fewer had a
sore throat, cough (for DF), nausea, vomiting, diarrhoea, abdom-
inal pain, anorexia or tachycardia than DF or DHF patients. From
the decision trees, platelets <118×109/L was the only distinguish-
ing feature for DF versus chikungunya with an overall correct
classiﬁcation of 89%. For DHF versus chikungunya using platelets
<100×109/L and the presence of bleeding, the overall correct clas-
siﬁcation was 98%. Even in the absence of laboratory variables it is
possible to discriminate well for DHF using the presence of bleed-
ing at presentation, with an overall correct classiﬁcation of 91%.
The time course analysis supported platelet count as the key dis-
tinguishing variable.
Conclusion: Our study shows a substantial overlap in clinical
presentation between these infections in adults, with implications
for disease surveillance and outpatient care in countries to which
both are endemic. It is, however, possible for clinicians to use sim-
ple clinical and laboratory variables to predict these infections for
appropriate management.
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